British Journal of Clinical Pharmacology · 1982 · 12 citations · 15 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacodynamicsBlood Pressure ManagementHemodynamic PharmacologyHypertension ControlHypertension ManagementHypertension PharmacotherapyAntihypertensive Drug TherapyAntihypertensive PharmacologyAntihypertensive TreatmentHypotension TreatmentTingling Sensation
1 Labetalol is an effective agent in essential hypertension as documented in open studies and controlled studies in which its efficacy has been compared with both placebo and a variety of other anti-hypertensive drugs. 2 Labetalol given by mouth lowers blood pressure rapidly. There is no evidence of tolerance to its anti-hypertensive action. 3 Adverse effects include excessive hypotension, but only when the drug is given in large doses. Epigastric discomfort and scalp tingling have been documented especially after intravenous administration. 4 From a pharmacokinetic and pharmacodynamic point of view, labetalol can be given once daily, but postural hypotension after large (greater than 1 g) single doses may limit the usefulness of once daily regimes. Twice daily administration appears an acceptable compromise.
15
Labetalol in long-term treatment of hypertension.
Prichard Bn, Boakes Aj · PubMed · 1976 · 80 citations
Trial of atenolol and chlorthalidone for hypertension in black South Africans.
Y K Seedat · BMJ · 1980 · 70 citations · Full text
Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.
Matthias Frick, P Pörsti · BMJ · 1976 · 47 citations · Full text
Controlled comparison of labetalol and propranolol in the management of severe hypertension.
D. J. Pugsley, Bruce K. Armstrong, Maria Nassim et al. · PubMed · 1976 · 47 citations
Medicine, Cardiology, Pharmacology +12